The positive predictive value for methylation in serum exceeded 70% for two genes, MGMT and RASSF1A. Combining methylation results from sputum and serum did not significantly improve sensitivity or specificity for predicting the methylation status in the tumour biopsy. This evidence concerns the gene MGMT and neoplasm.